Primary Care Clinics in Dillon, MT Accepting Medicare
8 Primary Care Clinics found. Showing 1 - 8
 Beaverhead Urgent Care Clinic/Center - Primary Care Medicare: Medicare Enrolled Practice Location: 120 S Atlantic St, Dillon, MT 59725 Phone: 406-683-4400 Fax: 406-683-4408 |
Blacktail Dental Clinic/Center Medicare: Medicare Enrolled Practice Location: 125 E Glendale St, Dillon, MT 59725 Phone: 406-683-4440 Fax: 406-683-1121 |
Barrett Hospital Development Corporation Clinic/Center - Primary Care Medicare: Medicare Enrolled Practice Location: 30 Mt Highway 91 S, Dillon, MT 59725 Phone: 406-683-3000 Fax: 406-683-3011 |
Sweet Medicine Therapy Llc Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 435 S Atlantic St, Suite 104, Dillon, MT 59725 Phone: 406-683-4453 Fax: 406-683-4453 |
Patricia A Grantham M.d. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 30 Mt Highway 91 S Ste 205, Dillon, MT 59725 Phone: 406-683-4252 |
C Curtis Blake M.d. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 30 Mt Highway 91 S Ste 206, Dillon, MT 59725 Phone: 406-683-4252 |
Burke E Hansen M.d. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 30 Mt Highway 91 S Ste 204, Dillon, MT 59725 Phone: 406-683-4252 |
Ag Worker Health & Services Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 116 N Washington St, Dillon, MT 59725 Phone: 406-683-5570 Fax: 406-683-6489 |
News Archive
Sinovac's inactivated EV71 vaccine clinical trial against HFMD receives Chinese SFDA approval
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that it received approval from the China State Food and Drug Administration (SFDA) to commence clinical trials for its proprietary inactivated EV71 vaccine against Hand, Foot and Mouth Disease (HFMD).
COCIR participates in EuroSafe session at ECR 2015
Today, at the European Congress of Radiation 2015, COCIR participated in the EuroSafe Call for Action. A European Society of Radiology initiative, ‘EuroSafe 2 – EuroSafe imaging call for action' was the second EuroSafe session at ECR 2015.
XBiotech to enter biosimilar business
XBiotech, a privately held biotechnology company, announced today that it is entering the biosimilar business. The Company is launching its biosimilar business with development of two of the world's leading therapeutic antibodies, one an oncology and the other an anti-inflammatory product.
First Edition: September 8, 2011
In today's headlines, reports from last night's GOP presidential debate, as well as explorations of what the future might hold for the 'Super Committee' and news developments related to physician payment issues.
› Verified 8 days ago